Published • loading... • Updated
DuChemBio Records 20.9 Billion Won in First-Half Sales Driven by Growth of 3 Diagnostic Products
Summary by 조선일보
1 Articles
1 Articles
Radiopharmaceutical company DuChemBio reported first-half performance higher than the previous year, driven by expanded sales of diagnostic agents for Alzheimer's, Parkinson's, and prostate cancer. On the 18th, DuChemBio announced that its revenue for the first half of this year reached 20.9 billion won, a 16.3% increase from the same period last year. Operating profit for the same period rose by 24.6% to 3.2 billion won. The company explained t…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
